Affimed N.V. (AFMD) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Wed March 10th, 2021

- 18:50
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisWhy Affimed N.V. Stock Is Soaring TodayThe Motley Fool

Thu January 14th, 2021

- 13:36
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisAffimed (AFMD) Catches Eye: Stock Jumps 8.8%Zacks

Sat December 19th, 2020

- 13:40
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisAffimed's Stockpile Of Partnerships Supports A Long-Term InvestmentSeeking Alpha

Tue November 10th, 2020

- 19:46
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisAffimed N.V. (AFMD) CEO Adi Hoess on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha
- 19:30
  EarningsAnalysisAffimed N.V. (AFMD) Q3 2020 Earnings Call TranscriptThe Motley Fool
- 15:20
  EarningsAnalysisAffimed N.V.'s (AFMD) CEO Adi Hoess On Q3 2020 Results - Quick Version Earnings Call TranscriptSeeking Alpha
- 12:55
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisAffimed N.V. (AFMD) Reports Q3 Loss, Tops Revenue EstimatesZacks + 3 more

Thu October 22nd, 2020

- 11:26
  AnalysisOraSure's Emergency Use Authorization, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Tue August 11th, 2020

- 15:41
  EarningsAnalysisAffimed N.V. (AFMD) CEO Adi Hoess on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha
- 11:55
  AnalysisAffimed N.V. (AFMD) Reports Q2 Loss, Lags Revenue EstimatesZacks + 1 more

Wed July 29th, 2020

- 16:33
  EarningsAnalysisAffimed N.V. (AFMD) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks

Fri July 24th, 2020

- 15:12
  AnalysisAffimed's Innate Immune Programs Offer A Compelling Value At Current Price LevelsSeeking Alpha

Wed July 1st, 2020

- 16:58
  AnalysisAffimed: Updates To Thesis, Time To Gain Exposure To Innate Immuno-OncologySeeking Alpha

Tue June 30th, 2020

- 15:03
  AnalysisWill Affimed Continue to Surge Higher?Zacks

Mon June 29th, 2020

- 12:43
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisImplied Volatility Surging for Affimed (AFMD) Stock OptionsZacks + 1 more

Tue June 23rd, 2020

- 20:30
  EarningsAnalysisAffimed N.V. (AFMD) Q1 2020 Earnings Call TranscriptThe Motley Fool
- 14:50
  EarningsAnalysisAffimed N.V. (AFMD) CEO Adi Hoess on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha + 1 more

Tue June 16th, 2020

- 13:47
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisAffimed (AFMD) Catches Eye: Stock Jumps 7.2%Zacks

SPY$395.63-3.2%

QQQ$315.85-5.7%

DOW$64.141.5%

CCF$115.74-1.5%

NVDA$513.35-10%

SPY$395.63-3.2%

QQQ$315.85-5.7%

DOW$64.141.5%

CCF$115.74-1.5%

NVDA$513.35-10%

About Developer Contact